3 ms·
They had very good, robust Phase II results. Thinks can go wrong in Phase III. Relyvrio (HIV vaccine) did well in P2 but flopped on P3. Cancer drug xevinapan
by fnord77 2y ago
They had very good, robust Phase II results.
Thinks can go wrong in Phase III.
Relyvrio (HIV vaccine) did well in P2 but flopped on P3.
Cancer drug xevinapant failed in P3 after Merck executives were reassuring analysts that the failure of a phase 3 trial of xevinapant was “unlikely.”